Heart1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 Heart News
Feature Story
 Education Center
Conditions
Procedures
Diagnostics
 Heart Attack Center
Prevention
Survivors
Dr. Tod Engelhardt  Heart
 Hero™

Dr. Tod Engelhardt:
Combating Major Blood Clots.
About Heroes
 Join the Discussion  in  Our Forums
 Community
Heart1 Forums
Patient Stories
 Reference
Online Resources
Video Library
advertisement
Search the Body1 Network
May 22, 2019  
HEART NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Boston Scientific Stent Is Approved

    Boston Scientific’s New Stent Is Approved


    March 05, 2004

    NATICK, Mass. (AP) - Boston Scientific Corp. said it would immediately launch a new stent that props open arteries and releases drugs into them after receiving final approval Thursday from federal regulators.

    The approval was expected following the unanimous recommendation by a Food and Drug Administration advisory panel in November. The device will compete with a product made by a Johnson & Johnson subsidiary that is already on the market.

    "This approval is a breakthrough event for the treatment of cardiovascular disease in the United States," said Jim Tobin, Boston Scientific's president and chief executive officer.

    Boston Scientific launched the Taxus Express2 stent in Europe in February.

    Last month, Guidant Corp. of Indianapolis and Miami Lakes, Fla.-based Cordis Corp., a unit of Johnson & Johnson, said they would settle patent suits and join forces to develop and market stent technology.

    Minneapolis-based Medtronic expects to introduce its drug-coated stent in the United States in late 2005.

    Stents are tiny scaffold-like mesh-metal tubes implanted into coronary arteries to prevent new blockages. The new models are coated with slow-release drugs to prevent scar tissue from forming.

    Before the announcement, shares of Boston Scientific closed up 97 cents at $44.12 on the New York Stock Exchange.


    Last updated: 05-Mar-04

    Comments

  • Add Comment
  •    
    Interact on Heart1

    Discuss this topic with others.
     
    Feature Archives

    Heart Disease Patients Need to Exercise to Benefit from the Protective Effects of Wine

    Effective Treatment for Heart Failure Possible Following Discovery of Heart Molecule

    Significant Decrease in Heart Disease after Prison Smoking Bans

    Heart Failure Patients Who Sleep Poorly Are at Double the Risk for Hospitalization

    Long-Term Survival Possible for Pediatric Heart Transplant Patients

    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    Plaques/fatty deposits as a cause for a heart attack

    Interview with James Spies, M.D. - The Effects of Less Functioning Vaults

    Interview with James Spies, M.D. about Treatments for Fibroids

    More Features ...
     
    Related Content
    Boston Scientific Presents Results from TAXUS Stent Trials at TCT

    FDA Panel Cautiously Backs New Stent

    New Heart Stent Promises to Be Effective But Costly Treatment

    Boston Scientific Anticipates Taxus Stent Launch

    FDA to Make Foods Reveal Trans Fat Levels

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2019 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.